Literature DB >> 2736498

The increasing frequency of adenocarcinoma of the esophagus.

P J Hesketh1, R W Clapp, W G Doos, S J Spechler.   

Abstract

Adenocarcinoma of the esophagus has been considered an uncommon tumor, accounting for fewer than 8% of all cases of esophageal cancer. To determine the current frequency of adenocarcinoma of the esophagus, we reviewed data from the tumor registries of the Commonwealth of Massachusetts, the University Hospital (UH), and the Boston VA Medical Center (BVAMC). From 1982 to 1984, 868 esophageal cancers were reported in Massachusetts, of which 231 (27%) were adenocarcinomas. In comparison with squamous cell carcinomas of the esophagus, esophageal adenocarcinomas occurred more frequently in males (P less than 0.01) and were uncommon among blacks (P less than 0.01). From 1980 to 1986, 262 cases of esophageal cancer were seen at the UH and the BVAMC, of which 81 (31%) were adenocarcinomas. An analysis of the latter group to identify true esophageal adenocarcinomas (tumors confined to the esophagus without gastric involvement) yielded 47 cases. Thus, true esophageal adenocarcinoma accounted for 18% of esophageal malignancies at our hospitals, a frequency threefold to fivefold higher than that found in four prior studies that used comparable anatomic diagnostic criteria. We conclude that adenocarcinoma of the esophagus is now being recognized at a substantially higher frequency than reported in the past.

Entities:  

Mesh:

Year:  1989        PMID: 2736498     DOI: 10.1002/1097-0142(19890715)64:2<526::aid-cncr2820640228>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  35 in total

1.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

Review 2.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Authors:  J Lagergren
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Treatment of carcinoma of the esophagus.

Authors:  A Watson
Journal:  Ann R Coll Surg Engl       Date:  1991-07       Impact factor: 1.891

Review 4.  Photodynamic therapy: a review.

Authors:  J S McCaughan
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

5.  Opposing time trends of peptic ulcer and reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 6.  Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem.

Authors:  M S Levine; J B Herman; E E Furth
Journal:  Abdom Imaging       Date:  1995 Jul-Aug

7.  Gastric juice protects against the development of esophageal adenocarcinoma in the rat.

Authors:  A P Ireland; J H Peters; T C Smyrk; T R DeMeester; G W Clark; S S Mirvish; T E Adrian
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

8.  DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma.

Authors:  D F Peng; M Razvi; H Chen; K Washington; A Roessner; R Schneider-Stock; W El-Rifai
Journal:  Gut       Date:  2008-07-29       Impact factor: 23.059

9.  Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia.

Authors:  G C Kabat; S K Ng; E L Wynder
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

10.  Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935-89.

Authors:  T Zheng; S T Mayne; T R Holford; P Boyle; W Liu; Y Chen; M Mador; J Flannery
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.